Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer

Published:2012-12-13 Issue:7 Volume:20 Page:828-837
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Cândido Eduardo Batista¹,Silva Luciana Maria²,Carvalho Andréa Teixeira³,Lamaita Rívia Mara⁴,Filho Roberto Mundim Porto¹,Cota Bianca Della Croce Vieira²,Silva-Filho Agnaldo Lopes da¹

Affiliation:

1. Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Horizonte, Brazil

2. Division of Biomedical Sciences, Laboratory of Molecular and Cell Biology, Fundação Ezequiel Dias, Belo Horizonte, Brazil

3. Laboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte, Brazil

4. Pró-Criar Clinic of Assisted Reproduction, MaterDei Hospital, Belo Horizonte, Brazil

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719112466299

Reference39 articles.

1. Ovarian cancer

2. Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin–paclitaxel chemotherapy

3. Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer

4. Cancer despite immunosurveillance: immunoselection and immunosubversion

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complex role of IL-10 in malignant ascites: a review;Cancer Immunology, Immunotherapy;2024-01-27

2. Systemic Inflammatory Patterns in Ovarian Cancer Patients: Analysis of Cytokines, Chemokines, and Microparticles;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2023-12

3. Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy;Frontiers in Immunology;2022-11-10

4. Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints;Cancers;2022-10-29

5. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance;Cells;2022-10-20